Pages that link to "Q73893249"

The following pages link to Soluble interleukin 6 (IL-6) receptor and IL-6 levels in serum and synovial fluid of patients with different arthropathies (Q73893249):

Displaying 31 items.

• Alternative intronic polyadenylation generates the interleukin-6 trans-signaling inhibitor sgp130-E10 (Q28654409) (← links)
• Biomarkers of oxidant stress, insulin sensitivity and endothelial activation in rheumatoid arthritis: a cross-sectional study of their association with accelerated atherosclerosis (Q33442034) (← links)
• gp130 at the nexus of inflammation, autoimmunity, and cancer (Q34378756) (← links)
• CTGF increases IL-6 expression in human synovial fibroblasts through integrin-dependent signaling pathway (Q34507247) (← links)
• Cadherin-11 regulates fibroblast inflammation (Q35002899) (← links)
• The role of synovial fluid markers of catabolism and anabolism in osteoarthritis, rheumatoid arthritis and asymptomatic organ donors. (Q35092953) (← links)
• Evidence-based recommendations for the management of undifferentiated peripheral inflammatory arthritis (UPIA). The German perspective on the international 3e initiative (Q35109668) (← links)
• The involvement of follistatin-like protein 1 in osteoarthritis by elevating NF-κB-mediated inflammatory cytokines and enhancing fibroblast like synoviocyte proliferation (Q35530208) (← links)
• Cytosolic phospholipase A2 modulates TLR2 signaling in synoviocytes (Q35609712) (← links)
• Involvement of IL-6, apart from its role in immunity, in mediating a chronic response during experimental arthritis (Q35829699) (← links)
• Study of active controlled monotherapy used for rheumatoid arthritis, an IL-6 inhibitor (SAMURAI): evidence of clinical and radiographic benefit from an x ray reader-blinded randomised controlled trial of tocilizumab (Q35954629) (← links)
• Expression of Semaphorin 4A and its potential role in rheumatoid arthritis (Q35995299) (← links)
• Clinical studies in patients with Castleman's disease, Crohn's disease, and rheumatoid arthritis in Japan (Q36243965) (← links)
• Cytokine profiles in localized scleroderma and relationship to clinical features (Q36784652) (← links)
• Gene polymorphisms and pharmacogenetics in rheumatoid arthritis (Q37214931) (← links)
• Acute anterior uveitis after discontinuation of tocilizumab in a patient with rheumatoid arthritis (Q37478085) (← links)
• The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis (Q37798162) (← links)
• Profile of sarilumab and its potential in the treatment of rheumatoid arthritis. (Q38745066) (← links)
• The role of the hypothalamic-pituitary-adrenal axis in modulating seasonal changes in immunity (Q39656925) (← links)
• Enhancement of anti-inflammatory tendency by SB203580, p38alpha specific inhibitor, in human fibroblast-like synoviocyte cell line, MH7A. (Q40305814) (← links)
• B-cell phenotype and IgD-CD27- memory B cells are affected by TNF-inhibitors and tocilizumab treatment in rheumatoid arthritis. (Q41500669) (← links)
• Recommendations of the German rheumatology society on the use of tocilizumab in rheumatoid arthritis (Q43871354) (← links)
• Neutrophil-related immunoinflammatory disturbance in steroid-overdosed ulcerative colitis patients (Q46287663) (← links)
• Beta2-microglobulin concentrations in cerebrospinal fluid correlate with neuroimaging findings in newborns with symptomatic congenital cytomegalovirus infection. (Q48543447) (← links)
• Identification of sarilumab pharmacodynamic and predictive markers in patients with inadequate response to TNF inhibition: a biomarker substudy of the phase 3 TARGET study. (Q52647587) (← links)
• Targeting Activated Synovial Fibroblasts in Rheumatoid Arthritis by Peficitinib (Q64118169) (← links)
• Inhibiting interleukin-6 in rheumatoid arthritis (Q82076763) (← links)
• Plasma soluble IL-6 receptor concentration in rheumatoid arthritis: associations with the rs8192284 IL6R polymorphism and with disease activity (Q84596969) (← links)
• Correlations between serum interleukin 6, serum soluble interleukin 6 receptor, and disease activity in systemic juvenile idiopathic arthritis patients treated with or without tocilizumab (Q90150209) (← links)
• Endogenous stimulation is responsible for the high frequency of IL-17A-producing neutrophils in patients with rheumatoid arthritis (Q92462388) (← links)
• Family-based analyses reveal novel genetic overlap between cytokine interleukin-8 and risk for suicide attempt (Q92891424) (← links)